A detailed history of Advisor Group Holdings, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 87,373 shares of PACB stock, worth $170,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,373
Previous 86,247 1.31%
Holding current value
$170,377
Previous $118,000 25.42%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.17 $1,351 - $2,443
1,126 Added 1.31%
87,373 $148,000
Q2 2024

Aug 13, 2024

SELL
$1.36 - $3.65 $12,887 - $34,587
-9,476 Reduced 9.9%
86,247 $118,000
Q1 2024

May 10, 2024

BUY
$3.52 - $9.59 $123,097 - $335,371
34,971 Added 57.56%
95,723 $358,000
Q4 2023

Feb 12, 2024

BUY
$5.97 - $10.36 $131,405 - $228,033
22,011 Added 56.82%
60,752 $595,000
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $15,093 - $25,547
-1,834 Reduced 4.52%
38,741 $323,000
Q2 2023

Aug 10, 2023

SELL
$9.97 - $14.05 $11,445 - $16,129
-1,148 Reduced 2.75%
40,575 $539,000
Q1 2023

May 12, 2023

BUY
$7.94 - $12.02 $37,675 - $57,034
4,745 Added 12.83%
41,723 $483,000
Q4 2022

Feb 10, 2023

BUY
$5.67 - $11.2 $139,754 - $276,057
24,648 Added 199.9%
36,978 $302,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $2,711 - $5,913
690 Added 5.93%
12,330 $72,000
Q2 2022

Aug 10, 2022

SELL
$4.02 - $10.43 $12,912 - $33,501
-3,212 Reduced 21.63%
11,640 $52,000
Q1 2022

May 04, 2022

BUY
$8.43 - $20.9 $53,783 - $133,342
6,380 Added 75.31%
14,852 $1.85 Million
Q3 2021

Nov 05, 2021

BUY
$24.86 - $35.02 $9,944 - $14,008
400 Added 4.96%
8,472 $216,000
Q2 2021

Aug 02, 2021

BUY
$22.3 - $36.02 $7,336 - $11,850
329 Added 4.25%
8,072 $284,000
Q1 2021

May 13, 2021

BUY
$26.38 - $51.15 $79,878 - $154,882
3,028 Added 64.22%
7,743 $258,000
Q4 2020

Feb 10, 2021

BUY
$10.5 - $28.5 $49,507 - $134,377
4,715 New
4,715 $123,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.